User login
The Food and Drug Administration announced today that Meridia (sibutramine), a drug used for treating obesity, will be voluntarily removed from the U.S. market by its maker, Abbott Laboratories. The withdrawal is the result of clinical trial data indicating an association between Meridia use and increased risk of heart attack and stroke.
The Food and Drug Administration announced today that Meridia (sibutramine), a drug used for treating obesity, will be voluntarily removed from the U.S. market by its maker, Abbott Laboratories. The withdrawal is the result of clinical trial data indicating an association between Meridia use and increased risk of heart attack and stroke.
The Food and Drug Administration announced today that Meridia (sibutramine), a drug used for treating obesity, will be voluntarily removed from the U.S. market by its maker, Abbott Laboratories. The withdrawal is the result of clinical trial data indicating an association between Meridia use and increased risk of heart attack and stroke.